17,261 trials
Schizophrenia
Primary: Change From Baseline in Cognitive Function as Measured by the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive…
Acute Myelogenous Leukemia
Primary: Progression Free Survival — 21 days
Renal Cell Carcinoma · Renal Cancer
Primary: Difference in Median Progression Free Survival Time Between Favorable and Unfavorable Biomarker Group
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change in Flow Mediated Dilation — 0.26; -1.5 percentage of flow mediated dilation
Carcinoma, Non-Small-Cell Lung
Primary: Objective Response Rate (ORR) — 16.7; 8.3 Percentage of Participants
Lymphoma
Primary: Complete Remission (CR) Rate — 0.62; 0.75 proportion of participants — p=0.02
Multiple Myeloma
Primary: Combined Therapy - Median Progression Free Survival — 36 months
Solid Tumor · Glioma · Angioimmunoblastic T-cell Lymphoma
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 3; 4; 6; 7 Participants
Dengue Fever · Dengue Hemorrhagic Fever
Primary: STAGE-I: Geometric Mean Titers (GMTs) Against Each Dengue Virus Serotype 28 Days After Last CYD Dengue Vaccination in Participants Who Were Seropositive at Baseline…
Uveitis · Intermediate Uveitis · Posterior Uveitis
Primary: Change in Intraocular Pressure (IOP) — -0.1 mm Hg
Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall · Stage II Bladder Cancer AJCC v8 · Stage II Renal Pelvis Cancer AJCC v8
Primary: Proportion of Participants With Complete Response (At 6 Months) — 0.5 proportion of participants
Prostate Cancer
Primary: Number of Biopsy-proven Cancers (Gleason 6+) That Standard Imaging (mpMRI) Would Have Missed Compared With High Resolution Diffusion-weighted Imaging (DWI) PET-hrMRI on…
Osteoarthritis, Knee
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 9; 4; 9; 8 Participants
Hypertension · Mild Cognitive Impairment
Primary: Executive Function — 87.23; 111.37 seconds
Alcoholism · Alcohol Use Disorder (AUD)
Primary: Frequency of Heavy Drinking Days by Medication Group (Timeline Follow Back Calendar). — 29.00; 41.25 Heavy drinking days